Pharma Focus Asia
KP - Sustainable Packaging Solutions

Vibalogics Invests US$150million to Expand Virotherapy Facility in Boston


Vibalogics with an investment of US$ 150 million plans to enter the US region to expand Virotherapy Facility. The new facility will be located in Boston.


The project features initial Phase I of the facility constructed with an area of 110,000 sq. Ft.

The new state-of-the-art facility consists of advanced technology which significantly enhances the size of the capacity which includes 2000L scale bioreactors and additional fill-finish capabilities.

The facility designed with new technology and virotherapy services will enhance the production of drug developers with most innovative products. Moreover, with the construction of a new state-of-the-art facility the consumer products can be made easily available from the early phase manufacturing facility in Germany to the US.

It is expected that the new clinical and commercial facility will create 100 jobs initially and reach out to 250 employees in the coming years.

The new project is expected to begin its operations by the second half of 2021.


TypeNew Manufacturing Facility
BudgetUS$150 million
YearQ2, 2021
Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?